These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 1915197)

  • 1. Dietary modification of Parkinson's disease.
    Croxson S; Johnson B; Millac P; Pye I
    Eur J Clin Nutr; 1991 May; 45(5):263-6. PubMed ID: 1915197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary method for reducing fluctuations in Parkinson's disease.
    Pincus JH; Barry KM
    Yale J Biol Med; 1987; 60(2):133-7. PubMed ID: 3577210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-lactalbumin combined with a regular diet increases plasma Trp-LNAA ratio.
    Beulens JW; Bindels JG; de Graaf C; Alles MS; Wouters-Wesseling W
    Physiol Behav; 2004 Jun; 81(4):585-93. PubMed ID: 15178151
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of large neutral amino acid supplements in PKU: an MRS and neuropsychological study.
    Schindeler S; Ghosh-Jerath S; Thompson S; Rocca A; Joy P; Kemp A; Rae C; Green K; Wilcken B; Christodoulou J
    Mol Genet Metab; 2007 May; 91(1):48-54. PubMed ID: 17368065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diet therapy in Parkinson disease].
    Vilming ST
    Tidsskr Nor Laegeforen; 1995 Apr; 115(10):1244-7. PubMed ID: 7754495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation.
    da Silva TM; Munhoz RP; Alvarez C; Naliwaiko K; Kiss A; Andreatini R; Ferraz AC
    J Affect Disord; 2008 Dec; 111(2-3):351-9. PubMed ID: 18485485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind trial of R-(-)-deprenyl for the "on-off" effect complicating Parkinson's disease.
    Golbe LI; Duvoisin RC
    J Neural Transm Suppl; 1987; 25():123-9. PubMed ID: 3123598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A double-blind, cross-over trial with madopar HBS in patients with Parkinson's disease.
    De Michele G; Mengano A; Filla A; Trombetta L; Campanella G
    Acta Neurol (Napoli); 1989 Dec; 11(6):408-14. PubMed ID: 2694799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Special low-protein foods ameliorate postprandial off in patients with advanced Parkinson's disease.
    Barichella M; Marczewska A; De Notaris R; Vairo A; Baldo C; Mauri A; Savardi C; Pezzoli G
    Mov Disord; 2006 Oct; 21(10):1682-7. PubMed ID: 16773618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a ketoacid-aminoacid-supplemented very low protein diet on the progression of advanced renal disease: a reanalysis of the MDRD feasibility study.
    Teschan PE; Beck GJ; Dwyer JT; Greene T; Klahr S; Levy AS; Mitch WE; Snetselaar LG; Steinman TI; Walser M
    Clin Nephrol; 1998 Nov; 50(5):273-83. PubMed ID: 9840314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized placebo-controlled trial of rasagiline in levodopa-treated patients with Parkinson disease and motor fluctuations: the PRESTO study.
    Parkinson Study Group
    Arch Neurol; 2005 Feb; 62(2):241-8. PubMed ID: 15710852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine A2A receptor antagonist istradefylline (KW-6002) reduces "off" time in Parkinson's disease: a double-blind, randomized, multicenter clinical trial (6002-US-005).
    LeWitt PA; Guttman M; Tetrud JW; Tuite PJ; Mori A; Chaikin P; Sussman NM;
    Ann Neurol; 2008 Mar; 63(3):295-302. PubMed ID: 18306243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
    Lou JS; Kearns G; Benice T; Oken B; Sexton G; Nutt J
    Mov Disord; 2003 Oct; 18(10):1108-14. PubMed ID: 14534913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial.
    Goetz CG; Damier P; Hicking C; Laska E; Müller T; Olanow CW; Rascol O; Russ H
    Mov Disord; 2007 Jan; 22(2):179-86. PubMed ID: 17094088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled study of intranasal apomorphine spray as a rescue agent for off-states in Parkinson's disease.
    Dewey RB; Maraganore DM; Ahlskog JE; Matsumoto JY
    Mov Disord; 1998 Sep; 13(5):782-7. PubMed ID: 9756146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CV 205-502: safety, tolerance to, and efficacy of increasing doses in patients with Parkinson's disease in a double-blind, placebo crossover study.
    Olanow CW; Werner EG; Gauger LL
    Clin Neuropharmacol; 1989 Dec; 12(6):490-7. PubMed ID: 2575014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diet in Parkinson disease].
    Håglin L; Selander B
    Tidsskr Nor Laegeforen; 2000 Feb; 120(5):576-8. PubMed ID: 10833916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A balanced carbohydrate: protein diet in the management of Parkinson's disease.
    Berry EM; Growdon JH; Wurtman JJ; Caballero B; Wurtman RJ
    Neurology; 1991 Aug; 41(8):1295-7. PubMed ID: 1866021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
    Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
    Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.